Jenifer Voeks to Risk Assessment
This is a "connection" page, showing publications Jenifer Voeks has written about Risk Assessment.
Connection Strength
0.266
-
Stroke Symptoms as a Surrogate in Stroke Primary Prevention Trials: The CREST Experience. Neurology. 2022 Nov 22; 99(21):e2378-e2384.
Score: 0.034
-
Treatment of carotid stenosis in asymptomatic, nonoctogenarian, standard risk patients with stenting versus endarterectomy trials. J Vasc Surg. 2022 04; 75(4):1276-1283.e1.
Score: 0.032
-
Long-term outcomes of stenting and endarterectomy for symptomatic carotid stenosis: a preplanned pooled analysis of individual patient data. Lancet Neurol. 2019 04; 18(4):348-356.
Score: 0.027
-
Duration of asymptomatic status and outcomes following carotid endarterectomy and carotid artery stenting in the Carotid Revascularization Endarterectomy vs Stenting Trial. J Vasc Surg. 2019 06; 69(6):1797-1800.
Score: 0.027
-
Developing a risk-based composite neurologic outcome for a trial of hydroxyurea in young children with sickle cell disease. Clin Trials. 2019 02; 16(1):20-31.
Score: 0.026
-
Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association. Circulation. 2018 03 20; 137(12):e67-e492.
Score: 0.025
-
Transcranial doppler re-screening of subjects who participated in STOP and STOP II. Am J Hematol. 2016 12; 91(12):1191-1194.
Score: 0.023
-
Carotid angiographic characteristics in the CREST trial were major contributors to periprocedural stroke and death differences between carotid artery stenting and carotid endarterectomy. J Vasc Surg. 2016 Apr; 63(4):851-7, 858.e1.
Score: 0.021
-
Management of vascular risk factors in the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST). J Am Heart Assoc. 2014 Nov 26; 3(6):e001180.
Score: 0.020
-
Differential outcomes of carotid stenting and endarterectomy performed exclusively by vascular surgeons in the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST). J Vasc Surg. 2013 Feb; 57(2):303-8.
Score: 0.017
-
Variations in prevalent cardiovascular disease and future risk by metabolic syndrome classification in the REasons for Geographic and Racial Differences in Stroke (REGARDS) study. Am Heart J. 2010 Mar; 159(3):385-91.
Score: 0.014